Literature DB >> 28318608

Multi-center evaluation of one commercial and 12 in-house real-time PCR assays for detection of Mycoplasma pneumoniae.

Roger Dumke1, Alvaro J Benitez2, Victoria Chalker3, Karolina Gullsby4, Birgit Henrich5, Carlos Hidalgo-Grass6, Theo Hoogenboezem7, Darja Kese8, Katherine Loens9, Jolanda Maaskant10, Ayelet Michael-Gayego11, Allon E Moses11, Ran Nir-Paz11, Suzan D Pas10, Sabine Pereyre12, Randi F Petersen13, Meike Rosenblatt5, Annemarie M C van Rossum14, Søren A Uldum13, Wendy W J Unger7, Dominique Ursi9, Jonas M Winchell2, Cecile Bebear12.   

Abstract

Detection of Mycoplasma pneumoniae by real-time PCR is not yet standardized across laboratories. We have implemented a standardization protocol to compare the performance of thirteen commercial and in-house approaches. Despite differences on threshold values of samples, all assays were able to detect at least 20M. pneumoniae genomes per reaction.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Detection; Multi-center evaluation; Mycoplasma pneumoniae; Real-time PCR

Mesh:

Substances:

Year:  2017        PMID: 28318608     DOI: 10.1016/j.diagmicrobio.2017.03.004

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  2 in total

1.  Mycoplasma pneumoniae detections before and during the COVID-19 pandemic: results of a global survey, 2017 to 2021.

Authors:  Patrick M Meyer Sauteur; Michael L Beeton; Søren A Uldum; Nathalie Bossuyt; Melissa Vermeulen; Katherine Loens; Sabine Pereyre; Cécile Bébéar; Darja Keše; Jessica Day; Baharak Afshar; Victoria J Chalker; Gilbert Greub; Ran Nir-Paz; Roger Dumke
Journal:  Euro Surveill       Date:  2022-05

2.  Mycoplasma pneumoniae infections, 11 countries in Europe and Israel, 2011 to 2016.

Authors:  Michael L Beeton; Xu-Sheng Zhang; Søren A Uldum; Cécile Bébéar; Roger Dumke; Karolina Gullsby; Margareta Ieven; Katherine Loens; Ran Nir-Paz; Sabine Pereyre; O Brad Spiller; Victoria J Chalker
Journal:  Euro Surveill       Date:  2020-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.